According to a recent report, clinical trials have begin at the University of Mississippi Medical Center to study the use of cannabidiol (also known as CBD) for the treatment of children with severe epilepsy. The initial trial will involve ten children from Mississippi with severe cases of epilepsy. Harper Grace’s Law, signed in 2014, made the way to make these kinds of research partnerships possible:
The trial, which will study the effect of cannabidiol—or CBD, as it’s known—on children with severe epilepsy, is the very first university-based clinical trial of a cannabis extract to meet federal standards. The agencies that had to sign off on the trial before it could start include the Food and Drug Administration, the Internal Review Board and the Drug Enforcement Administration.
Read more here.